{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:42:47Z","timestamp":1785426167128,"version":"3.56.0"},"reference-count":54,"publisher":"S.C. JURNALUL PENTRU MEDICINA SI VIATA S.R.L","issue":"5","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMedLife"],"DOI":"10.25122\/jml-2021-0081","type":"journal-article","created":{"date-parts":[[2021,12,31]],"date-time":"2021-12-31T09:07:17Z","timestamp":1640941637000},"page":"594-599","source":"Crossref","is-referenced-by-count":24,"title":["Alcoholic liver disease-from steatosis to cirrhosis - a biochemistry approach"],"prefix":"10.25122","volume":"14","author":[{"given":"Ruxandra","family":"Cioarca-Nedelcu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Biochemistry Department, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"*Corresponding Author: Ruxandra Cioarca-Nedelcu, Biochemistry Department, University of Medicine and Pharmacy Carol Davila, 14 Ceahlau Street, District 6, Bucharest, Romania, PO: 060379. Phone: 0727061533; E-mail: ruxinedelcu@gmail.com","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Biochemistry Department, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Biochemistry Department, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeriu","family":"Atanasiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Stoian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10755","published-online":{"date-parts":[[2021,1]]},"reference":[{"key":"ref1","unstructured":"1. Mann RE, Smart RG, Govoni R. The epidemiology of alcoholic liver disease. Alcohol Res Heal. 2003;27(3):209\u201319."},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"2. Lieber CS. Alcohol: Its metabolism and interaction with nutrients. Annu Rev Nutr. 2000;20:395\u2013430.","DOI":"10.1146\/annurev.nutr.20.1.395"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"3. Gramenzi A, Caputo F, Biselli M, Kuria F, Loggi E, Andreone P, Bernardi M. Review article: Alcoholic liver disease - Pathophysiological aspects and risk factors. Aliment Pharmacol Ther. 2006;24(8):1151\u201361.","DOI":"10.1111\/j.1365-2036.2006.03110.x"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"4. Louvet A, Mathurin P. Alcoholic liver disease: Mechanisms of injury and targeted treatment. Nat Rev Gastroenterol Hepatol. 2015;12(4):231\u201342.","DOI":"10.1038\/nrgastro.2015.35"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"5. Crabb DW, Matsumoto M, Chang D, You M. Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology. Proc Nutr Soc. 2004;63(1):49\u201363.","DOI":"10.1079\/PNS2003327"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"6. Lu Y, Cederbaum AI. CYP2E1 and oxidative liver injury by alcohol. Free Radic Biol Med. 2008;44(5):723\u201338.","DOI":"10.1016\/j.freeradbiomed.2007.11.004"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"7. Meijers R, Morris RJ, Adolph HW, Merli A, Lamzin VS, Cedergren-Zeppezauer ES. On the Enzymatic Activation of NADH. J Biol Chem. 2001;276(12):9316\u201321.","DOI":"10.1074\/jbc.M010870200"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"8. Setshedi M, Wands JR, De La Monte SM. Acetaldehyde adducts in alcoholic liver disease. Oxid Med Cell Longev. 2010;3(3):178\u201385.","DOI":"10.4161\/oxim.3.3.12288"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"9. Van Vleet TR, Philip BK. Acetaldehyde. Encycl Toxicol Third Ed. 2014;22\u20133.","DOI":"10.1016\/B978-0-12-386454-3.00994-5"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"10. Lieber CS. Alcoholic fatty liver: Its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol. 2004;34(1):9\u201319.","DOI":"10.1016\/j.alcohol.2004.07.008"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"11. Wu D, Cederbaum AI. Oxidative stress and alcoholic liver disease. Semin Liver Dis. 2009;29(2):141\u201354.","DOI":"10.1055\/s-0029-1214370"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"12. Hoek JB, Pastorino JG. Ethanol, oxidative stress, and cytokine-induced liver cell injury. Alcohol. 2002;27(1):63\u20138.","DOI":"10.1016\/S0741-8329(02)00215-X"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"13. Hirano T. Alcohol consumption and oxidative DNA damage. Int J Environ Res Public Health. 2011;8(7):2895\u2013906.","DOI":"10.3390\/ijerph8072895"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"14. Gonzalez FJ. The 2006 Bernard B. Brodie award lecture CYP2E1. Drug Metab Dispos. 2007;35(1):1\u20138.","DOI":"10.1124\/dmd.106.012492"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"15. Linhart K, Bartsch H, Seitz HK. The role of reactive oxygen species (ROS) and cytochrome P-450 2E1 in the generation of carcinogenic etheno-DNA adducts. Redox Biol. 2014;3:56\u201362.","DOI":"10.1016\/j.redox.2014.08.009"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"16. Bansal S, Liu CP, Sepuri NBV, Anandatheerthavarada HK, Selvaraj V, Hoek J, Milne GL, Guengerich FP, Avadhani NG. Mitochondria-targeted cytochrome P450 2E1 induces oxidative damage and augments alcohol-mediated oxidative stress. J Biol Chem. 2010;285(32):24609\u201319.","DOI":"10.1074\/jbc.M110.121822"},{"key":"ref17","unstructured":"17. Cederbaum AI. CYP2E1 - Biochemical and toxicological aspects and role in alcohol-induced liver injury. Mt Sinai J Med. 2006;73(4):657\u201372."},{"key":"ref18","unstructured":"18. Wu D, Cederbaum AI. Alcohol, oxidative stress, and free radical damage. Alcohol Res Heal. 2003;27(4):277\u201384."},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"19. Ha HL, Shin HJ, Feitelson MA, Yu DY. Oxidative stress and antioxidants in hepatic pathogenesis. World J Gastroenterol. 2010;16(48):6035\u201343.","DOI":"10.3748\/wjg.v16.i48.6035"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"20. Ribas V, Garc\u00eda-Ruiz C, Fern\u00e1ndez-Checa JC. Glutathione and mitochondria. Front Pharmacol. 2014;5 JUL.; doi:10.3389\/fphar.2014.00151.","DOI":"10.3389\/fphar.2014.00151"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"21. Sozio M, Crabb DW. Alcohol and lipid metabolism. Am J Physiol - Endocrinol Metab. 2008;295(1); doi:10.1152\/ajpendo.00011.2008.","DOI":"10.1152\/ajpendo.00011.2008"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"22. Koch OR, Pani G, Borrello S, Colavitti R, Cravero A, Farr\u00e8 S, Galeotti T. Oxidative stress and antioxidant defenses in ethanol-induced cell injury. Mol Aspects Med. 2004;25(1\u20132):191\u20138.","DOI":"10.1016\/j.mam.2004.02.019"},{"key":"ref23","unstructured":"23. Mokhtari V, Afsharian P, Shahhoseini M, Kalantar SM, Moini A. A review on various uses of N-acetyl cysteine. Cell J. 2017;19(1):11\u20137."},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"24. Stickel F, Seitz HK. Alcoholic steatohepatitis. Best Pract Res Clin Gastroenterol. 2010;24(5):683\u201393.","DOI":"10.1016\/j.bpg.2010.07.003"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"25. Federico A, Dallio M, Loguercio C. Silymarin\/Silybin and chronic liver disease: A marriage of many years. Molecules. 2017;22(2); doi:10.3390\/molecules22020191.","DOI":"10.3390\/molecules22020191"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"26. El-Zayadi AR. Hepatic steatosis: A benign disease or a silent killer. World J Gastroenterol. 2008;14(26):4120\u20136.","DOI":"10.3748\/wjg.14.4120"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"27. Sid B, Verrax J, Calderon PB. Role of AMPK activation in oxidative cell damage: Implications for alcohol-induced liver disease. Biochem Pharmacol. 2013;86(2):200\u20139.","DOI":"10.1016\/j.bcp.2013.05.007"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"28. Liangpunsakul S, Sozio MS, Shin E, Zhao Z, Xu Y, Ross RA, Zeng Y, Crabb DW. Inhibitory effect of ethanol on AMPK phosphorylation is mediated in part through elevated ceramide levels. Am J Physiol - Gastrointest Liver Physiol. 2010;298(6); doi: 10.1152\/ajpgi.00482.200.","DOI":"10.1152\/ajpgi.00482.2009"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"29. Staels B, Maes M, Zambon A. Fibrates and future PPAR\u03b1 agonists in the treatment of cardiovascular disease. Nat Clin Pract Cardiovasc Med. 2008;5(9):542\u201353.","DOI":"10.1038\/ncpcardio1278"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"30. You M, Crabb DW. Molecular mechanisms of alcoholic fatty liver: Role of sterol regulatory element-binding proteins. Alcohol. 2004;34(1):39\u201343.","DOI":"10.1016\/j.alcohol.2004.07.004"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"31. Hu J, Zhu XH, Ye L, Hong W, Yao KN, Chen ZY. Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT\/mTOR\/SREBP-1 signaling pathway. World J Gastroenterol. 2019;25(12):1492\u2013501.","DOI":"10.3748\/wjg.v25.i12.1492"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"32. Wang GL, Fu YC, Xu WC, Feng YQ, Fang SR, Zhou XH. Resveratrol inhibits the expression of SREBP1 in cell model of steatosis via Sirt1-FOXO1 signaling pathway. Biochem Biophys Res Commun. 2009;380(3):644\u20139.","DOI":"10.1016\/j.bbrc.2009.01.163"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"33. Lally JSV, Ghoshal S, DePeralta DK, Moaven O, Wei L, Masia R, Erstad DJ, Fujiwara N, Leong V, Houde VP, Anagnostopoulos AE, Wang A, Broadfield LA, Ford RJ, Foster RA, Bates J, Sun H, Wang T, Liu H, Ray AS, Saha AK, Greenwood J, Bhat S, Harriman G, Miao W, Rocnik JL, Westlin WF, Muti P, Tsakiridis T, Harwood HJ, Kapeller R, Hoshida Y, Tanabe KK, Steinberg GR, Fuchs BC. Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma. Cell Metab. 2019;29(1):174-182.e5.","DOI":"10.1016\/j.cmet.2018.08.020"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"34. Ramirez T, Tong M, Chen WC, Nguyen QG, Wands JR, De la Monte SM. Chronic alcohol-induced hepatic insulin resistance and endoplasmic reticulum stress ameliorated by peroxisome-proliferator activated receptor-\u03b4 agonist treatment. J Gastroenterol Hepatol. 2013;28(1):179\u201387.","DOI":"10.1111\/j.1440-1746.2012.07256.x"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"35. Kolios G, Valatas V, Kouroumalis E. Role of Kupffer cells in the pathogenesis of liver disease. World J Gastroenterol. 2006;12(46):7413\u201320.","DOI":"10.3748\/wjg.v12.i46.7413"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"36. Wan J, Benkdane M, Teixeira-Clerc F, Bonnafous S, Louvet A, Lafdil F, Pecker F, Tran A, Gual P, Mallat A, Lotersztajn S, Pavoine C. M2 Kupffer cells promote M1 Kupffer cell apoptosis: A protective mechanism against alcoholic and non-alcoholic fatty liver disease. Hepatology. 2014;59(1):130\u201342.","DOI":"10.1002\/hep.26607"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"37. Marra F, Tacke F. Roles for chemokines in liver disease. Gastroenterology. 2014;147(3).","DOI":"10.1053\/j.gastro.2014.06.043"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"38. Szabo G, Bala S. Alcoholic liver disease and the gut-liver axis. World J Gastroenterol. 2010;16(11):1321\u20139.","DOI":"10.3748\/wjg.v16.i11.1321"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"39. Szabo G. Gut-liver axis in alcoholic liver disease. Gastroenterology. 2015;148(1):30\u20136.","DOI":"10.1053\/j.gastro.2014.10.042"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"40. Leclercq S, Cani PD, Neyrinck AM, St\u00e4rkel P, Jamar F, Mikolajczak M, Delzenne NM, De Timary P. Role of intestinal permeability and inflammation in the biological and behavioral control of alcohol-dependent subjects. Brain Behav Immun. 2012;26(6):911\u20138.","DOI":"10.1016\/j.bbi.2012.04.001"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"41. Forsyth CB, Farhadi A, Jakate SM, Tang Y, Shaikh M, Keshavarzian A. Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis. Alcohol. 2009;43(2):163\u201372.","DOI":"10.1016\/j.alcohol.2008.12.009"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"42. Roh YS, Seki E. Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis. J Gastroenterol Hepatol. 2013;28(SUPPL 1):38\u201342.","DOI":"10.1111\/jgh.12019"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"43. Li Y, Trush MA. Diphenyleneiodonium, an NAD(P)H oxidase inhibitor, also potently inhibits mitochondrial reactive oxygen species production. Biochem Biophys Res Commun. 1998;253(2):295\u20139.","DOI":"10.1006\/bbrc.1998.9729"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"44. Lieber CS, Robins SJ, Jianjun L, DeCarli LM, Mak KM, Fasulo JM, Leo MA. Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon. Gastroenterology. 1994;106(1):152\u20139.","DOI":"10.1016\/S0016-5085(94)95023-7"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"45. Czaja AJ. Hepatic inflammation and progressive liver fibrosis in chronic liver disease. World J Gastroenterol. 2014;20(10):2515\u201332.","DOI":"10.3748\/wjg.v20.i10.2515"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"46. Friedman SL. Mechanisms of Hepatic Fibrogenesis. Gastroenterology. 2008;134(6):1655\u201369.","DOI":"10.1053\/j.gastro.2008.03.003"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"47. Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 2017;14(7):397\u2013411.","DOI":"10.1038\/nrgastro.2017.38"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"48. Paik YH, Brenner DA. NADPH oxidase mediated oxidative stress in hepatic fibrogenesis. Korean J Hepatol. 2011;17(4):251\u20137.","DOI":"10.3350\/kjhep.2011.17.4.251"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"49. Richter K, Kietzmann T. Reactive oxygen species and fibrosis: further evidence of a significant liaison. Cell Tissue Res. 2016;365(3):591\u2013605.","DOI":"10.1007\/s00441-016-2445-3"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"50. Rodr\u00edguez LR, Calap-Quintana P, Lape\u00f1a-Luz\u00f3n T, Pallard\u00f3 F V., Schneuwly S, Navarro JA, Gonzalez-Cabo P. Oxidative stress modulates rearrangement of endoplasmic reticulum-mitochondria contacts and calcium dysregulation in a Friedreich\u2019s ataxia model. Redox Biol. 2020; doi: 10.1016\/j.redox.2020.101762.","DOI":"10.1101\/2020.03.27.011528"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"51. Bataller R, Brenner DA. Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin Liver Dis. 2001;21(3):437\u201351.","DOI":"10.1055\/s-2001-17558"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"52. Xia SW, Wang ZM, Sun SM, Su Y, Li ZH, Shao JJ, Tan SZ, Chen AP, Wang SJ, Zhang ZL, Zhang F, Zheng SZ. Endoplasmic reticulum stress and protein degradation in chronic liver disease. Pharmacological Research. 2020; doi: 10.1016\/j.phrs.2020.10521.","DOI":"10.1016\/j.phrs.2020.105218"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"53. Hayes KE, Batsomboon P, Chen WC, Johnson BD, Becker A, Eschrich S, Yang Y, Robart AR, Dudley GB, Geldenhuys WJ, Hazlehurst LA. Inhibition of the FAD containing ER oxidoreductin 1 (Ero1) protein by EN-460 as a strategy for treatment of multiple myeloma. Bioorganic Med Chem. 2019; doi: 10.1016\/j.bmc.2019.02.01.","DOI":"10.1016\/j.bmc.2019.02.016"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"54. Mantena SK, King AL, Andringa KK, Eccleston HB, Bailey SM. Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases. Free Radical Biology and Medicine. 2008; doi: 10.1016\/j.freeradbiomed.2007.12.029.","DOI":"10.1016\/j.freeradbiomed.2007.12.029"}],"container-title":["Journal of Medicine and Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/medandlife.org\/wp-content\/uploads\/2.-jml-2021-0081.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,31]],"date-time":"2021-12-31T09:07:38Z","timestamp":1640941658000},"score":1,"resource":{"primary":{"URL":"https:\/\/medandlife.org\/wp-content\/uploads\/2.-jml-2021-0081.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["JMedLife-14-594"],"URL":"https:\/\/doi.org\/10.25122\/jml-2021-0081","relation":{},"ISSN":["1844-122X","1844-3117"],"issn-type":[{"value":"1844-122X","type":"print"},{"value":"1844-3117","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}